Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Barinthus Biotherapeutics plc.Barinthus Biotherapeutics Reports Mixed Financial Results, Shifts Focus to Key Product Candidates
BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Significant Financial Developments Following Merger with BlackRock Capital Investment Corporation
Scienture Holdings, Inc.Scienture Holdings Reports Significant Financial Changes, Including 83% Revenue Decline and 337% Operating Expense Increase in Latest Quarter
CONDUENT IncConduent Reports 13% Revenue Decline, Turnaround in Profitability in Q3 2024
Coya Therapeutics, Inc.Coya Therapeutics Reports 9-Month Financial Results, Collaboration Revenue Growth, and Strategic Advancements in Clinical Programs
Coupang, Inc.Coupang Reports 27% Revenue Growth, Operating Income Increase in Q3 2024
NewAmsterdam Pharma Co N.V.NewAmsterdam Pharma Reports 890% Revenue Growth, Improved Operating Loss in Latest Quarter
UroGen Pharma Ltd.UroGen Pharma Reports Increased Revenue and Assets, Widening Losses in Q3 2024
Praxis Precision Medicines, Inc.Praxis Precision Medicines Reports Significant Financial Developments, Increased Cash Reserves, and Ongoing Operating Losses
Paysign, Inc.Paysign, Inc. Reports 23% Revenue Growth, Net Income Increase in Q3 2024
AMERICAN ELECTRIC POWER CO INCAmerican Electric Power Reports Strong Financial Performance in Q3 2024, with Revenues and Net Income Up
LENZ Therapeutics, Inc.LENZ Therapeutics Reports Improved Liquidity, Reduced Losses Following Merger and PIPE Financings
Tango Therapeutics, Inc.Tango Therapeutics Reports Revenue Growth, Increased Expenses, and Net Loss in Q3 2024
Lantheus Holdings, Inc.Lantheus Holdings Reports 18.4% Revenue Growth to $378.7 Million in Q3 2024
VISHAY INTERTECHNOLOGY INCVishay Intertechnology Reports Significant Revenue and Profit Declines in Q3 2024
Dine Brands Global, Inc.Dine Brands Global Reports Decline in Revenues and Profitability in Q3 2024
Latham Group, Inc.Latham Group Reports Mixed Q3 Results Amid Challenging Market Conditions
RAND CAPITAL CORPRand Capital Corporation Reports Strong Financial Performance in Q3 2024, with Increased Investment Income and Net Asset Value
Lineage, Inc.Lineage, Inc. Reports Mixed Q3 2024 Results, Net Loss Widens Amid Higher Operating Expenses and Strategic Developments
Katapult Holdings, Inc.Katapult Holdings Reports 10% Revenue Growth, Widened Losses in Q3 2024
Immunocore Holdings plcImmunocore Holdings plc Reports 23.7% Revenue Growth, Strong Cash Reserves in Q3 2024
STARWOOD PROPERTY TRUST, INC.Starwood Property Trust Reports Mixed Q3 Results, Net Income Up 40% Amid Revenue Decline
CVS HEALTH CorpCVS Health Reports 6.3% Revenue Growth, 96.9% Decline in Net Income in Q3 2024
National Vision Holdings, Inc.National Vision Holdings Reports Mixed Financial Results, Strategic Developments for Q3 2024
MASIMO CORPMasimo Corporation Reports Mixed Q3 Results, Healthcare Segment Growth Offset by Non-Healthcare Decline